You signed in with another tab or window. Reload to refresh your session.You signed out in another tab or window. Reload to refresh your session.You switched accounts on another tab or window. Reload to refresh your session.Dismiss alert
Chimerix, Inc. was a biopharmaceutical company headquartered in Durham, North Carolina, focused on developing medicines for serious and life-threatening diseases. It is best known for brincidofovir (TEMBEXA), an antiviral approved by the U.S.
Pardes Biosciences was a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing novel therapeutics to treat and prevent viral diseases. Founded in 2020 and based in Carlsbad, California, it used structure-based drug design and a tunable, reversible covalent chemistry platform.
Novira Therapeutics was a biopharmaceutical company developing direct-acting antivirals for chronic hepatitis B (HBV), notably HBV capsid assembly modulators. It was acquired by Johnson & Johnson (Janssen) in 2015 and no longer operates as an independent entity.